Vitamin D Flashcards
1
Q
Vitamin D Background: First use, disease, etc.
A
- Ocean phytoplankton:
- First sunscrren, photochemical signaling
- Anti-rachitic (cod liver oil/sunlight)
- Bowed legs/rosary knobbed ribs
- Smog with industrialization
- C sections
- Heat denatured cod liver oil cured rickets, not vitamin A
- UV radiate one arm cured whole body-hormone?
- D2 and D3 are pro-hormones→converted to hormone 1,25Dihydroxy D3
- Maintain serum ca/phosphate
2
Q
Two main forms of Vitamin D
A
- secosteroids
- B ring split by light
- D1: lumisterol and Vitamin D2
- Tried to make D2 from ergosterol
-
D3: Cholecalciferol
- Skin to UVB
- From 7-dehydrocholesterol
-
D2: Ergocalciferol
- Plants
- From ergosterol
3
Q
Potency of D2 versus D3
A
- Use D3
- More effective at increasing 25,OH-D
- What is measured in blood
- Metabolites bind stronger to VDR
- D2 half shorter shelf life
4
Q
Synthesis/Activation of D3
A
- Be able to draw
- 7-Dehydrocholesterol (Pro-VitD3)→Pre-VitD3 with UV light
- Pre-VitD3→VitD3 with heat
- VitD3→25-OHD3 (Calcidiol)
- Bioactivation in liver; 25-Hydroxylase
- CYP2R1 (rickets); CYP27A1
- Calcidiol→1,25(OH)2D3 (Calcitrol-active)
- kidney; CYP27B1; 1 alpha hydroxylase
- Most important control point
- CYP24A1 inactivates to Calcitroic acid
- CYP3A4 and CYP24A1 to 1,24/23,25 (OH)3D3
- Drug induced osteomelacia with phenytoin
- UGT1A4 to glucoronide
5
Q
Photoactivation of 7-Dehydrocholesterol
A
- Be able to draw
- At 295 nm; need sun >45º above horizon; 35th parallel
- B ring absorb photon
- [1,7] hydrogen shift
6
Q
Vitamin D Receptor Activation
A
- 1,25 DHCC binds to VDR (hormone receptor)
- VDR heterodimerizes with RXR and goes to VDRE
- Promoter of calbindin and osteocalcin/ostepontin (bone forming)
7
Q
Vitamin D and Calcium Homeostasis Pathway
A
- VDR actiation of calbindin and ca transporters (TRPV5-kidney and TRPV6-gut)
- Calcium: teeth/bone, clotting, synapse, muscle
- Low calcium→PTH
- PTH→increase bone/kidney resorption, kidney calcidiol→calcitrol
- → increase fut absortion
- →Calcium sensor→GPCR→Negative feedback
- Kidney failure
- Decrease ca resorption, decreased activation
- Low Ca; Increased PTH
- Bone resorption; metabolic bone disease
8
Q
VDR in Cell Proliferation/Differentiation
A
- High intake may reduce risk of certain cancer
- Calcitrol promotes apoptosis
- VDR polymorphisms and cancers
- Inconsistent data on protective effect of vitD
- Overall decreased death due to all causes
9
Q
Vitamin D sources
A
- Fish, sun, effs, liver, milk
- Cod liver oil=400IU/5ml
10
Q
Vitamin D: DV, UL, RDA
A
- DV: 400 IU
- UL:4,000 IU
- RDA: 600 IU (800 >70yo)
- 1 µg=40 IU
11
Q
Vitamin D toxicity
A
- Hypercalcification
- Over a period of time
- Under 12
- 1-4 mo of 1,000 mg (40,000 IU)
- Adults: 2,500 mg (100,000 IU) in a few months
12
Q
VitD Deficency
A
- Assesed on 25-OH D3
- Natural if in sun=50-70 ng/ml
- Min to prevent ricket and osteomalacia: 15 ng/mL
- Deficency if <20 ng/ml (15 mmol)
13
Q
At risk for vitamin D deficiency
A
- Minmal sun (oldsters and youngster)
- Dark skin
- Religous skin cover
- Fat malabsorption
- Kidney failure
- Phenytoin (CYP3A4)
14
Q
Vitamin D Use
A
- 700-900 IU/day prevent fracture in postmenopausal
- Renal failure
- hypocalcemia and secondary hyperparathyroidism
- Rocaltrol (1, 25DHCC)
- Paricalcitol, modification of calcitrol; 1 mg TIW
15
Q
Vitamin D Consumer Counseling and Advice (4)
A
- At least 400 IU/day-Multivit
- If minimal sun; 800 IU/day
- bone, reduce cancer risk
- Postmenopausal should take vitD supplement and calcium supplement